Current through Register 2024 Notice Reg. No. 38, September 20, 2024
(a) At least
30 days before the event in which the athlete intends to compete, (1) a transgender
female athlete who applies to compete in women's competitions, or (2) a transgender
male athlete who applies to compete in men's competitions, shall submit their
Application.
(1) No Application will be granted on
an emergency basis.
(2) No Application
will be granted on a retroactive basis.
(b) Transgender female athletes who apply to
compete in women's competitions:
(1) A transgender
female athlete who has had a gonadectomy shall also include as part of her
Application:
(A) Written confirmation by a
State-licensed physician or Doctor of Osteopathic Medicine has confirmed that
hormone therapy has been administered by a Health Care Provider for a minimum of 2
years after gonadectomy.
(B) A letter
from the State-licensed physician or Doctor of Osteopathic Medicine responsible for
the care of the applicant that must include the following:
(i) Name of surgeon who performed the gonadectomy
and the date and location of surgery;
(ii) Initial date hormone therapy began after
gonadectomy (and prior to surgery, if relevant);
(iii) Hormone name/type, dose and interval of
administration over the past two years;
(iv) Name, dose and duration of any anti-androgen
treatment used over the past two years.
(2) A transgender female athlete who is undergoing
hormone therapy but has not had a gonadectomy shall also include as part of her
Application:
(A) Written confirmation by a
State-licensed physician or Doctor of Osteopathic Medicine that hormone therapy has
been administered by a Health Care Provider for a minimum of two years.
(B) A letter from the State-licensed physician or
Doctor of Osteopathic Medicine responsible for the care of the applicant that must
include the following:
(i) Initial date hormone
therapy began;
(ii) Hormone name/type,
dose and interval of administration over the past two years;
(iii) Lab reports of estradiol and testosterone
levels with a goal of serum estradiol levels within the normal range for healthy
premenopausal women (lab specific) and suppression of testosterone levels to those
normally found in women (lab specific) for the past two years;
(iv) Name, dose and duration of any anti-androgen
treatment used over the past two years.
(c) Transgender male athletes who apply to compete
in men's competitions:
(1) The athlete's
Application shall also include:
(A) Confirmation
from a State-licensed physician or Doctor of Osteopathic Medicine that hormone
therapy has been administered by a Health Care Provider for a minimum of 2
years.
(B) A letter from the
State-licensed physician or Doctor of Osteopathic Medicine responsible for the care
of the applicant that must include the following:
(i) Initial date of hormone therapy;
(ii) Hormone name/type, dose and interval of
administration for the past six months;
(iii) Lab reports of estradiol and testosterone
levels for the past six months with a goal of serum estradiol levels within the
normal range for healthy men (lab specific) and testosterone levels within the range
for healthy men (lab specific).
(d) If the commission denies an Application
submitted pursuant to this Chapter, the athlete may appeal that decision; such
appeal must be submitted in writing to the commission within seven (7) days of the
Commission's decision. The commission will set the matter for hearing within thirty
(30) days.
1. New section
filed 9-15-2016; operative 1-1-2017 (Register 2016, No. 38).
Note: Authority cited: Section 18611, Business and Professions
Code. Reference: Sections 18640, 18642, 18648, 18660, 18661, 18711 and 18712,
Business and Professions Code.
